Search Result

Results for "

Naproxen

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Apoptosis (1) Autophagy (6) Biochemical Assay Reagents (2) COX (18) Cytochrome P450 (1) Drug Derivative (1) Drug Intermediate (7) Drug Metabolite (2) Endogenous Metabolite (1) FLT3 (1) Isotope-Labeled Compounds (4) Ligands for Target Protein for PROTAC (1) PROTACs (1) Ras (2) Reference Standards (7) Trk Receptor (2)
By Research Areas:	Cancer (14) Inflammation/Immunology (19) Neurological Disease (2)

Inhibitors & Agonists

Screening Libraries

Biochemical Assay Reagents

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-15030

*Naproxen* 5+ Cited Publications (S)-Naproxen	COX Autophagy	Inflammation/Immunology Cancer
Naproxen is a COX-1 and COX-2 inhibitor with IC₅₀s of 8.72 and 5.15 μM, respectively in cell assay.

HY-15030A

Naproxen sodium 5+ Cited Publications	Autophagy COX	Inflammation/Immunology Cancer
Naproxen sodium is a COX-1 and COX-2 inhibitor with IC₅₀s of 8.72 and 5.15 μM, respectively in cell assay.

HY-15029

(±)-Naproxen (Rac)-Naproxen; 2-(6-Methoxynaphthalen-2-yl)propanoic acid	COX	Inflammation/Immunology Cancer
(±)-Naproxen ((Rac)-Naproxen) is a racemate of Naproxen (HY-15030). Naproxen is a COX-1 and COX-2 inhibitor with IC₅₀s of 8.72 and 5.15 μM, respectively.

HY-15031

l-Naproxen (R)-Naproxen	Ras	Cancer
l-Naproxen ((R)-Naproxen) is an enantiomer of (S)-Naproxen. l-Naproxen can inhibit Cdc42 and Rac1 (EC₅₀=96 μM and 212 μM, respectively), and show anti-tumor activity. l-Naproxen is a nonsteroidal antiinflammatory agent (NSAID) .

HY-15030R

Naproxen (Standard) (S)-Naproxen (Standard)	Reference Standards COX Autophagy	Inflammation/Immunology Cancer
Naproxen (Standard) is the analytical standard of Naproxen. This product is intended for research and analytical applications. Naproxen is a COX-1 and COX-2 inhibitor with IC₅₀s of 8.72 and 5.15 μM, respectively in cell assay.

HY-W145493

Glycofurol Tetraglycol; Poly(ethylene glycol) tetrahydrofurfuryl ether	Biochemical Assay Reagents	Others
Glycofurol (Tetraglycol) is a hydrophilic, water-miscible cosolvent and absorption enhancer with skin tolerance. Glycofurol can be used as a carrier-based gel for the topical delivery of drugs, including water-insoluble drugs. Glycofurol can form gels with bioadhesiveness, spreadability and suitable viscosity for topical administration .

HY-B2121

6-Methoxy-2-naphthoic acid 6-MNA; Naproxen impurity O	Drug Metabolite COX	Neurological Disease Inflammation/Immunology
6-Methoxy-2-naphthoic acid (6-MNA) is the active metabolite of Nabumetone (HY-B0559). 6-Methoxy-2-naphthoic acid is also an inhibitor of COX-1 and COX-2. 6-Methoxy-2-naphthoic acid can inhibit the synthesis of gastric mucosal prostaglandin E₂. 6-Methoxy-2-naphthoic acid can be used in the research of inflammation and pain-related diseases. In addition, 6-Methoxy-2-naphthoic acid is an impurity in Naproxen (HY-15030) and can also be used in the synthesis of other active compounds .

HY-W121901

Naproxen glucuronide (S)-Naproxen-β-D-glucuronide	COX	Inflammation/Immunology
Naproxen glucuronide ((S)-Naproxen-β-D-glucuronide) is a non-selective COX inhibitor. Naproxen glucuronide, a metabolite of naproxen, is a nonsteroidal anti-inflammatory drug (NSAID) of the propionic acid class (the same as ibuprofen) that relieves pain, fever, swelling, and stiffness .

HY-15029S

*(±)-Naproxen-d3* (Rac)-Naproxen-d₃	COX Isotope-Labeled Compounds	Inflammation/Immunology
(±)-Naproxen-d₃ is the deuterium labeled (±)-Naproxen. (±)-Naproxen is a non-steroidal anti-inflammatory drug (NSAID) .

HY-Y0038

2-Bromo-6-methoxynaphthalene	Trk Receptor	Cancer
2-Bromo-6-methoxynaphthalene is an active intermediate in the production of anti-inflammatory agents like Naproxen and Nabumetone by Heck reaction. 2-Bromo-6-methoxynaphthalene has potential anti-inflammatory properties and Tyrosine-protein inhibitor properties. 2-Bromo-6-methoxynaphthalene can be used for the research of cancer .

HY-W702781

1,3-Distearin 1,3-Distearoyl glycerol; Glyceryl 1,3-distearate; DG(18:0/0:0/18:0)	Drug Intermediate	Inflammation/Immunology
1,3-Distearin (1,3-Distearoyl glycerol) is an intermediate for synthesizing non-steroidal anti-inflammatory agents, and can be used in the synthesis of Ibuprofen (HY-78131), Naproxen (HY-15030), Diclofenac (HY-15036), and other non-steroidal anti-inflammatory agents .

HY-W024951

Naproxen impurity 5	Drug Intermediate	Others
Naproxen impurity 5 is an impurity of Naproxen.

HY-131495

(S)-6-O-Desmethylnaproxen (S)-6-Desmethyl Naproxen	COX	Inflammation/Immunology
(S)-6-O-Desmethylnaproxen ((S)-6-Desmethyl Naproxen) is a metabolite of the non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (+)-naproxen ((S)-naproxen). (S)-6-O-Desmethylnaproxen is formed from (S)-naproxen by the cytochrome P450 (CYP) isoforms CYP1A2 and CYP2C9.

HY-132405S

*Desmethyl Naproxen-d3*	COX Autophagy	Others
Desmethyl Naproxen-d₃ is deuterium labeled Desmethyl Naproxen. Desmethyl Naproxen is the metabolite of anti-inflammatory agent Naproxen .

HY-15030S1

Naproxen-d3 (S)-Naproxen-d₃	Isotope-Labeled Compounds COX Autophagy	Inflammation/Immunology Cancer
Naproxen-d₃ ((S)-Naproxen-d₃) is the deuterium labeled Naproxen (HY-15030). Naproxen is a COX-1 and COX-2 inhibitor with IC₅₀s of 8.72 and 5.15 μM, respectively in cell assay.

HY-157213

LWY713	Apoptosis PROTACs FLT3	Cancer
LWY713 is a PROTAC-class FLT3 degrader (DC₅₀=0.64 nM), which selectively induces FLT3 degradation via cereblon and proteasome-dependent pathways. LWY713 inhibits cell proliferation and induces G0/G1 phase arrest and apoptosis in MV4-11 cells. LWY713 shows effective in vivo antitumor activity in MV4-11 xenograft models . LWY713 consists of a target protein ligand (red part) Gilteritinib (HY-12432), an E3 ubiquitin ligase ligand (blue part) Lenalidomide-F (HY-W039233), and a PROTAC linker (black part) Glycolic acid (HY-W015967). E3 ubiquitin ligase and linker can form Lenalidomide-Glycolic acid (HY-169373); the active control for the target protein ligand is Naproxen Gilteritinib (HY-169374).

HY-W777599

*(±)-Naproxen-13C,d3-1* (Rac)-Naproxen-¹³C,d₃-1	Isotope-Labeled Compounds	Others
(±)-Naproxen- ¹³C,d₃-1 ((Rac)-Naproxen- ¹³C,d₃-1) is ¹³C and deuterium labeled (±)-Naproxen .

HY-15029R

*(±)-Naproxen* (Standard)** (Rac)-Naproxen (Standard); 2-(6-Methoxynaphthalen-2-yl)propanoic acid (Standard)	Reference Standards COX	Inflammation/Immunology Cancer
(±)-Naproxen (Standard) is the analytical standard of (±)-Naproxen. This product is intended for research and analytical applications. (±)-Naproxen ((Rac)-Naproxen) is a racemate of Naproxen (HY-15030). Naproxen is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively.

HY-15031R

*l-Naproxen* (Standard)** (R)-Naproxen (Standard)	Ras Reference Standards	Cancer
l-Naproxen (Standard) is the analytical standard of l-Naproxen. This product is intended for research and analytical applications.

HY-W339645

Naproxen ethyl ester (S)-Naproxen ethyl ester	COX	Inflammation/Immunology
Naproxen ethyl ester ((S)-Naproxen ethyl ester) is a nonsteroidal anti-inflammatory drug with activity in relieving pain, fever, swelling and stiffness. Naproxen ethyl ester exerts its effects by inhibiting non-selective cyclooxygenase (COX). The R-(-)-isomer of Naproxen ethyl ester shows stronger immunogenicity, and the Michaelis-Menten parameter of its catalytic reaction is K(M)=6.67 mM, and the catalytic efficiency is 5.8 x 10^4 times higher than that of the non-catalytic reaction .

HY-15030AR

Naproxen sodium (Standard)	Reference Standards Autophagy COX	Inflammation/Immunology Cancer
Naproxen (sodium) (Standard) is the analytical standard of Naproxen (sodium). This product is intended for research and analytical applications. Naproxen sodium is a COX-1 and COX-2 inhibitor with IC₅₀s of 8.72 and 5.15 μM, respectively in cell assay.

HY-15029S2

*(±)-Naproxen-13C,d3*	COX	Cancer
(±)-Naproxen- ¹³C,d₃ is the deuterium and ¹³C labeled (±)-Naproxen . (±)-Naproxen ((Rac)-Naproxen) is a racemate of Naproxen (HY-15030). Naproxen is a COX-1 and COX-2 inhibitor with IC₅₀s of 8.72 and 5.15 μM, respectively.

HY-W699926

*(R)-Naproxen* acyl-β-D-glucuronide** (R)-Naproxen-β-D-glucuronide	Biochemical Assay Reagents
(R)-Naproxen acyl-β-D-glucuronide ((R)-Naproxen-β-D-glucuronide) is a compound metabolite with anti-inflammatory activity. (R)-Naproxen acyl-β-D-glucuronide can serve as a sensitive fluorescent substrate for proglutamyl peptidase 1, which produces a blue reaction after cleavage.

HY-15029S1

*(±)-Naproxen-d3-1* (Rac)-Naproxen-d₃-1 (α-methyl-d₃)	COX Isotope-Labeled Compounds	Others
(±)-Naproxen-d₃-1 is the deuterium labeled (±)-Naproxen .

HY-19675

Naproxen etemesil LT-NS 001; MX 1094	COX	Inflammation/Immunology
Naproxen etemesil is a lipophilic, non-acidic, inactive proagent of naproxen that is hydrolysed to pharmacologically active Naproxen once absorbed. Naproxen is a COX-1 and COX-2 inhibitor with IC₅₀s of 8.72 and 5.15 μM, respectively in cell assay.

HY-169374

Naproxen Gilteritinib	Ligands for Target Protein for PROTAC	Cancer
Naproxen Gilteritinib is the active reference substance of Gilteritinib (HY-12432). Gilteritinib is the target protein ligand of PROTAC degrader LWY713 (HY-157213) .

HY-131495R

(S)-6-O-Desmethylnaproxen (Standard) (S)-6-Desmethyl Naproxen (Standard)	Cytochrome P450 Reference Standards	Inflammation/Immunology
(S)-6-O-Desmethylnaproxen (Standard) is the analytical standard of (S)-6-O-Desmethylnaproxen. This product is intended for research and analytical applications. (S)-6-O-Desmethylnaproxen ((S)-6-Desmethyl Naproxen) is a metabolite of the non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (+)-naproxen ((S)-naproxen). (S)-6-O-Desmethylnaproxen is formed from (S)-naproxen by the cytochrome P450 (CYP) isoforms CYP1A2 and CYP2C9.

HY-131411

Naproxen methyl ester	Drug Derivative	Inflammation/Immunology
Naproxen methyl ester is a prodrug of Naproxen (HY-15030) and an ester derivative. Naproxen methyl ester is promising for research of arthritis and other inflammatory conditions ¹.

HY-B2121R

6-Methoxy-2-naphthoic acid (Standard) 6-MNA (Standard); Naproxen impurity O (Standard)	Reference Standards Drug Metabolite COX	Neurological Disease Inflammation/Immunology
6-Methoxy-2-naphthoic acid (Standard) (6-MNA (Standard)) is the analytical standard of 6-Methoxy-2-naphthoic acid (HY-B2121). This product is intended for research and analytical applications. 6-Methoxy-2-naphthoic acid (6-MNA) is the active metabolite of Nabumetone (HY-B0559). 6-Methoxy-2-naphthoic acid is also an inhibitor of COX-1 and COX-2. 6-Methoxy-2-naphthoic acid can inhibit the synthesis of gastric mucosal prostaglandin E₂. 6-Methoxy-2-naphthoic acid can be used in the research of inflammation and pain-related diseases. In addition, 6-Methoxy-2-naphthoic acid is an impurity in Naproxen (HY-15030) and can also be used in the synthesis of other active compounds.

HY-Y0038R

2-Bromo-6-methoxynaphthalene (Standard)	Reference Standards Trk Receptor	Cancer
2-Bromo-6-methoxynaphthalene (Standard) is the analytical standard of 2-Bromo-6-methoxynaphthalene. This product is intended for research and analytical applications. 2-Bromo-6-methoxynaphthalene is an active intermediate in the production of anti-inflammatory agents like Naproxen and Nabumetone by Heck reaction. 2-Bromo-6-methoxynaphthalene has potential anti-inflammatory properties and Tyrosine-protein inhibitor properties. 2-Bromo-6-methoxynaphthalene can be used for the research of cancer .

HY-14931

Naproxcinod AZD 3582; HCT 3012; NitroNaproxen	COX	Inflammation/Immunology
Naproxcinod (Nitronaproxen) is the first in class of cyclooxygenase (COX)-inhibiting nitric oxide donators (CINODs). Naproxcinod shows analgesic and anti-inflammatory effects, it can be used for the research of osteoarthritis and inflammation .

HY-W196977

Naproxen impurity 6 Naproxen Nitrile impurity	Drug Intermediate	Others
Naproxen impurity 6 (Naproxen Nitrile impurity) is an impurity of Naproxen.

HY-W250826

Naproxen impurity 1	Drug Intermediate	Others
Naproxen impurity 1 is an impurity of Naproxen.

HY-W016788

Naproxen impurity 4	Drug Intermediate	Others
Naproxen impurity 4 is an impurity of Naproxen.

HY-Z8568

Naproxen impurity 2	Drug Intermediate	Others
Naproxen impurity 2 is an impurity of Naproxen.

HY-Z8569

Naproxen impurity 3	Drug Intermediate	Others
Naproxen impurity 3 is an impurity of Naproxen.

HY-118756

Anirolac RS37326	Endogenous Metabolite	Inflammation/Immunology
Anirolac (RS37326) is a nonsteroidal anti-inflammatory agent with analgesic activity. Anirolac showed analgesic efficacy comparable to that of naproxen in suppressing moderate or severe postpartum uterine pain. Anirolac induced significantly higher analgesia scores than placebo within 6 hours, especially at the 100 mg dose. Anirolac effectively relieved pain and showed a stronger analgesic effect than placebo in every assessment .

Cat. No.	Product Name

HY-L130

Non-steroidal Anti-Inflammatory Compound Library	627 compounds
Non-steroidal anti-inflammatory drugs (NSAIDs) are members of a therapeutic drug class with potent anti-inflammatory, analgesic and antipyretic activity, and are among the most widely used drugs worldwide. The most prominent NSAIDs are aspirin, ibuprofen, and naproxen. The main mechanism of action of NSAIDs is the inhibition of the enzyme cyclooxygenase (COX), based on which NSAIDs can be classified into two types: non-selective and COX-2 selective. Most NSAIDs are non-selective and inhibit both COX-1 and COX-2 activity. MCE offers a unique collection of 627 non-steroidal compounds with identified anti-inflammatory activity. MCE non-steroidal anti-inflammatory library is a useful tool for the study of anti-inflammatory drugs and pharmacology.

Non-steroidal Anti-Inflammatory Compound Library

627 compounds

Non-steroidal anti-inflammatory drugs (NSAIDs) are members of a therapeutic drug class with potent anti-inflammatory, analgesic and antipyretic activity, and are among the most widely used drugs worldwide. The most prominent NSAIDs are aspirin, ibuprofen, and naproxen.

The main mechanism of action of NSAIDs is the inhibition of the enzyme cyclooxygenase (COX), based on which NSAIDs can be classified into two types: non-selective and COX-2 selective. Most NSAIDs are non-selective and inhibit both COX-1 and COX-2 activity.

MCE offers a unique collection of 627 non-steroidal compounds with identified anti-inflammatory activity. MCE non-steroidal anti-inflammatory library is a useful tool for the study of anti-inflammatory drugs and pharmacology.

Cat. No.	Product Name	Type